CRKL and rhabdomyosarcoma: CrkL knockdown also inhibited cell proliferation in rhabdomyosarcoma [33], MDA-MB-453 breast cancer [34], MKN-45 gastric cancer [35], hepatocellular carcinoma [39], and HeLa cell lines [36].